BlueChip Wealth Advisors LLC Invests $557,000 in UnitedHealth Group Incorporated (NYSE:UNH)

BlueChip Wealth Advisors LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,057 shares of the healthcare conglomerate’s stock, valued at approximately $557,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Ables Iannone Moore & Associates Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $1,310,000. Leo Wealth LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $525,000. Yeomans Consulting Group Inc. bought a new position in UnitedHealth Group during the fourth quarter worth $320,000. Golden Road Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter worth $304,000. Finally, MONECO Advisors LLC boosted its position in UnitedHealth Group by 127.8% during the fourth quarter. MONECO Advisors LLC now owns 8,698 shares of the healthcare conglomerate’s stock worth $4,579,000 after purchasing an additional 4,879 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Piper Sandler lifted their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Finally, Royal Bank of Canada dropped their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $7.96 during midday trading on Monday, reaching $489.16. The company’s stock had a trading volume of 2,406,691 shares, compared to its average volume of 4,138,703. The stock has a market cap of $450.22 billion, a PE ratio of 29.90, a price-to-earnings-growth ratio of 1.44 and a beta of 0.58. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The business has a 50-day moving average price of $494.22 and a 200-day moving average price of $505.48. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business posted $6.26 earnings per share. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be issued a $2.10 dividend. The ex-dividend date is Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.72%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.